# Iron Fatigue Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/iron-fatigue-meta-analysis-evidence-review
Category: evidence-review
Summary: Iron Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomed
Last reviewed: 2026-06-01
Reviewed by: Migaku Evidence Review
# Iron Fatigue Meta-analysis: What the Evidence Says

## Quick Answer

Iron Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation | narrative review | 3 | 2026-02-04 | 10.3390/healthcare14030393 |
| Restless Legs Syndrome and Neurological Comorbidities: A Narrative Review | preclinical study | 4 | 2026-05-12 | 10.3390/jcm15103725 |

## What The Sources Report

- IBD-associated anemia has a significant impact on patients' physical and cognitive functioning, increases hospitalization rates, and reduces quality of life. [Hren Rok (2026); evidence level 3]
- The objectives of the present study are therefore twofold: (i) to extend previous pharmacoeconomic evaluations by incorporating the current Slovenian cost environment, and (ii) to place these economic findings within the context of the latest clinical evidence, including recent systematic reviews and expert consensus statements. [Hren Rok (2026); evidence level 3]
- In addition, central lesions such as pontine stroke or spinal demyelinating plaques, and peripheral small-fiber neuropathies, have all been associated with RLS symptoms. [Ghattas Kyrillos (2026); evidence level 4]
- Nocturnal leg cramps are usually painful, focal, and associated with muscle tightening rather than an urge to move. [Ghattas Kyrillos (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For iron fatigue meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Hren Rok (2026). The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation. DOI: 10.3390/healthcare14030393. PMCID: PMC12897823. PMID: 41682243. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12897823/
- Ghattas Kyrillos (2026). Restless Legs Syndrome and Neurological Comorbidities: A Narrative Review. DOI: 10.3390/jcm15103725. PMCID: PMC13206992. PMID: 42194685. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13206992/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.